[go: up one dir, main page]

AU2001261371A1 - Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same - Google Patents

Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same

Info

Publication number
AU2001261371A1
AU2001261371A1 AU2001261371A AU6137101A AU2001261371A1 AU 2001261371 A1 AU2001261371 A1 AU 2001261371A1 AU 2001261371 A AU2001261371 A AU 2001261371A AU 6137101 A AU6137101 A AU 6137101A AU 2001261371 A1 AU2001261371 A1 AU 2001261371A1
Authority
AU
Australia
Prior art keywords
same
uropathogenic
escherichia coli
type
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261371A
Inventor
Xue-Ru Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York University NYU
Original Assignee
New York University NYU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York University NYU filed Critical New York University NYU
Publication of AU2001261371A1 publication Critical patent/AU2001261371A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4233—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-bacterial Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU2001261371A 2000-05-16 2001-05-10 Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same Abandoned AU2001261371A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20457200P 2000-05-16 2000-05-16
US60204572 2000-05-16
PCT/US2001/015095 WO2001087233A2 (en) 2000-05-16 2001-05-10 Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof

Publications (1)

Publication Number Publication Date
AU2001261371A1 true AU2001261371A1 (en) 2001-11-26

Family

ID=22758473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001261371A Abandoned AU2001261371A1 (en) 2000-05-16 2001-05-10 Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same

Country Status (3)

Country Link
US (1) US6632431B2 (en)
AU (1) AU2001261371A1 (en)
WO (1) WO2001087233A2 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020145A (en) * 1989-06-30 2000-02-01 Bristol-Myers Squibb Company Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
US20030035797A1 (en) * 1992-01-27 2003-02-20 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US6297041B1 (en) * 1992-03-11 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US5776746A (en) * 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
US5853977A (en) * 1996-07-12 1998-12-29 Schering Corporation Mammalian TNF-α convertases
PL201533B1 (en) * 1999-01-13 2009-04-30 Igeneon Krebs Immuntherapie Use of antibodies for anticancer vaccination
US20040265318A1 (en) * 1999-01-13 2004-12-30 Igeneon Krebs-Immunotherapie Forschungs-und Entwicklungs-AG Use of antibodies for the vaccination against cancer
FR2793497B1 (en) * 1999-05-10 2003-04-18 Centre Nat Rech Scient MONOCLONAL ANTIBODIES DIRECTED AGAINST HUMAN RENAL CARCINOMA CELLS
US7740845B2 (en) 2000-10-18 2010-06-22 Sloan-Kettering Institute For Cancer Research Uses of monoclonal antibody 8H9
US8501471B2 (en) 2000-10-18 2013-08-06 Sloan-Kettering Institute For Cancer Research Uses of monoclonal antibody 8H9
US8414892B2 (en) 2000-10-18 2013-04-09 Sloan-Kettering Institute For Cancer Research Uses of monoclonal antibody 8H9
US7666424B2 (en) * 2001-10-17 2010-02-23 Sloan-Kettering Institute For Cancer Research Methods of preparing and using single chain anti-tumor antibodies
US7737258B2 (en) * 2000-10-18 2010-06-15 Sloan-Kettering Institute For Cancer Research Uses of monoclonal antibody 8H9
US7244814B2 (en) * 2002-02-21 2007-07-17 University Of Medicine & Dentistry Of New Jersey Variant Tat proteins and methods for use thereof
US7053188B2 (en) * 2002-02-22 2006-05-30 Purdue Research Foundation Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
US8088569B2 (en) * 2002-03-01 2012-01-03 Applied Immune Technologies Immunogens for treatment of neoplastic and infectious disease
MXPA06003886A (en) * 2003-10-08 2006-08-11 Ebioscience Native immunoglobulin binding reagents and methods for making and using same.
WO2007056411A2 (en) * 2005-11-08 2007-05-18 Genentech, Inc. Method of producing pan-specific antibodies
KR20100014527A (en) * 2007-03-22 2010-02-10 슬로안-케테링인스티튜트퍼캔서리서치 Uses of monoclonal antibody 8h9
EP3693379A1 (en) 2015-05-13 2020-08-12 University of Washington Compositions and methods for treatment and prevention of uropathogenice. coli

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801690A (en) * 1986-03-24 1989-01-31 Bactex, Inc. Novel lectins derived from bacterial pili
US4725435A (en) * 1986-06-18 1988-02-16 Bactex, Inc. Vaccine composition for immunization against urinary tract infection caused by E. coli
US5656271A (en) * 1993-03-19 1997-08-12 The Johns Hopkins University Oral vaccine comprising anti-idiotypic antibody to chlamydia glycolipid exoantigen and process
US5840297A (en) * 1993-03-19 1998-11-24 Johns Hopkins University Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process
DE4336530C1 (en) * 1993-10-26 1995-04-13 Max Planck Gesellschaft Recombinant PilC proteins, process for their preparation and their use
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6290959B1 (en) * 1996-10-24 2001-09-18 New York University Method for screening compounds for inhibiting bacterial attachment to host cell receptors
AU3702800A (en) * 1999-02-22 2000-09-14 University Of British Columbia, The Caulobacter lps immunoadjuvant

Also Published As

Publication number Publication date
US6632431B2 (en) 2003-10-14
US20020028200A1 (en) 2002-03-07
WO2001087233A2 (en) 2001-11-22
WO2001087233A3 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
AU2001261371A1 (en) Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions containing same and method for using same
AUPR879601A0 (en) Novel chemical compounds and their use
AU2001241474A1 (en) Biosensor compositions and methods of use
AU2001259604A1 (en) Novel quaternary compounds, compositions containing them, and uses thereof
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
HUP0301745A3 (en) Cyclopentanoindoles, compositions containing such compounds and their use
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
AU2002333278A1 (en) Solid composition containing Bacillus-type non-pathogenic bacterial spores
HUP0402024A3 (en) Solid composition containing bacillus-type non-pathogenic bacterial spores
AU2001274181A1 (en) Composition and method for biocide treatment of surfaces
AU2002220378A1 (en) Regulation of bacterial virulence
AU2001272961A1 (en) Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
AU2001273972A1 (en) Hair treatment composition
AUPR879701A0 (en) Novel chemical compounds and their use
AU2002357356A1 (en) Novel antifungal bacterium and compositions
AU2002326303A1 (en) Methods for attenuation of virulence in bacteria
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
IL162524A0 (en) Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application
AU8987998A (en) Oligonucleotide specific of the (escherichia coli) species and method for detecting and displaying bacteria of this species
AU2002214975A1 (en) Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds
AU2002336752A1 (en) Composition for treating streptococcus pneumoniae
AU2002219295A1 (en) Disinfecting peroxosilicated compound with scale preventive effect, preparation method and use thereof
AU2001274966A1 (en) Novel long acting, reversible veterinary sedative and analgesic and method of use
AU2001273357A1 (en) Controlling data-on-demand client access
AU2002223679A1 (en) Hair treatment composition